A
Cameron Eidmann alleged Walgreens misled customers into believing its private-label product, which costs four times more than the “children’s version,” is specially formulated for infants when both have the same concentration of active ingredient.
The suit was dismissed in February. No reasonable consumer would understand the infants’ product to be so designed, Judge Edward J. Davila of the U.S. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.